Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.
Also called NCT01946815
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 119 participants
- Sponsor
- Registry
-
NCT01946815
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01946815. Allocation not applicable; no masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2018-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease
- Acronym
- FORTE
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Atorvastatin
- Lead sponsor
- Keimyung University Dongsan Medical Center
- Collaborator
- Seoul National University Hospital
- Collaborator
- Ulsan University Hospital
- Collaborator
- Inje University Ilsan Paik Hospital
Record details
- Record id
cardio:ct-nct01946815- Content hash
c06b9e2d1fc947454b674015dc652e3e5b412c39c771f747b1983c68cf9a0d7d